Apella Capital LLC Sells 20 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Apella Capital LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,167 shares of the healthcare conglomerate’s stock after selling 20 shares during the period. Apella Capital LLC’s holdings in UnitedHealth Group were worth $590,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in UNH. M&T Bank Corp raised its stake in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its position in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. grew its stake in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP bought a new stake in shares of UnitedHealth Group in the third quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after buying an additional 1,051 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH opened at $543.21 on Thursday. The stock has a market capitalization of $499.91 billion, a PE ratio of 35.39, a P/E/G ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $554.45 and its 200-day moving average is $563.12.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, Barclays lifted their price target on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.